Sweet syndrome associated with 13-cis-retinoic acid (isotretinoin) therapy
Ágnes Gyórfy MD
Department of Pediatrics, Medical and Health Science Center University of Debrecen, Debrecen, Hungary
Search for more papers by this authorTamás Kovács MD
Department of Pediatrics, Medical and Health Science Center University of Debrecen, Debrecen, Hungary
Search for more papers by this authorIstván Szegedi MD
Department of Pediatrics, Medical and Health Science Center University of Debrecen, Debrecen, Hungary
Search for more papers by this authorÉva Oláh MD, PhD, DSc
Department of Pediatrics, Medical and Health Science Center University of Debrecen, Debrecen, Hungary
Search for more papers by this authorCorresponding Author
Csongor Kiss MD, PhD
Department of Pediatrics, Medical and Health Science Center University of Debrecen, Debrecen, Hungary
Department of Pediatrics, MHSC, University of Debrecen, H-4012 Debrecen, P.O. Box 32, Hungary.Search for more papers by this authorÁgnes Gyórfy MD
Department of Pediatrics, Medical and Health Science Center University of Debrecen, Debrecen, Hungary
Search for more papers by this authorTamás Kovács MD
Department of Pediatrics, Medical and Health Science Center University of Debrecen, Debrecen, Hungary
Search for more papers by this authorIstván Szegedi MD
Department of Pediatrics, Medical and Health Science Center University of Debrecen, Debrecen, Hungary
Search for more papers by this authorÉva Oláh MD, PhD, DSc
Department of Pediatrics, Medical and Health Science Center University of Debrecen, Debrecen, Hungary
Search for more papers by this authorCorresponding Author
Csongor Kiss MD, PhD
Department of Pediatrics, Medical and Health Science Center University of Debrecen, Debrecen, Hungary
Department of Pediatrics, MHSC, University of Debrecen, H-4012 Debrecen, P.O. Box 32, Hungary.Search for more papers by this author
REFERENCES
- 1 Sweet RD. An acute febrile neutrophilic dermatosis. Br J Dermatol 1964; 76: 349–356.
- 2 Boatman BW, Taylor RC, Klein LE, et al. Sweet's syndrome in children. South Med J 1994; 87: 193–196.
- 3 Veres K, Haraszti A, Nemes Z, et al. Sweet syndrome following therapeutic use of granulocyte colony stimulating factor. Orv Hetil 1999; 140: 1059–1061.
- 4 Torok L, Kirschner A, Gurzo M, et al. Leukemic neutrophilic dermatosis. Orv Hetil 1999; 140: 715–718.
- 5 Karolyi Z, Eros N, Ujszaszy L, et al. Cutaneous and mucosal manifestations of inflammatory bowel diseases. Orv Hetil 2000; 141: 1391–1395.
- 6 Levi I, Raanani P, Shalmon B, et al. Acute neutrophilic dermatosis incuded by all-trans retinoic acid treatment for acute promyelocytic leukemia. Leuk Lymphoma 1999; 34: 401–404.
- 7 Takada S, Matumoto K, Sakura T, et al. Sweet's syndrome followed by retinoic acid syndrome during the treatment of acute promyelocytic leukemia with all-trans retinoic acid. Int J Hematol 1999; 70: 26–29.
- 8 Tomasini C, Aloi F, Osella-Abate S, et al. Immature myeloid precursors in chronic neutrophilic dermatosis associated with myelodysplastic syndrome. Am J Dermathopathol 2000; 22: 429–433.
- 9 Magro CM, De Moraes E, Burns USA. Sweet's syndrome in the setting of CD34-positive acute myelogenous leukemia treated with granulocyte colony stimulating factor: evidence for a clonal neutrophilic dermatosis. J Cutan Pathol 2001; 28: 90–96.
